SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-003481
Filing Date
2022-02-08
Accepted
2022-02-08 16:28:37
Documents
14
Period of Report
2022-02-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46588
2 ex99-1.htm EX-99.1 13815
  Complete submission text file 0001493152-22-003481.txt   284908

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ensc-20220208.xsd EX-101.SCH 3778
4 XBRL DEFINITION FILE ensc-20220208_def.xml EX-101.DEF 26881
5 XBRL LABEL FILE ensc-20220208_lab.xml EX-101.LAB 36943
6 XBRL PRESENTATION FILE ensc-20220208_pre.xml EX-101.PRE 25503
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5593
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 22601986
SIC: 2834 Pharmaceutical Preparations